Alex Pham , Edgar Robitaille , Chris Bradley , Joshua de Souza , Jithin Yohannan
{"title":"Development and Evaluation of an Artificial Intelligence Model to Set Target IOP for Glaucoma","authors":"Alex Pham , Edgar Robitaille , Chris Bradley , Joshua de Souza , Jithin Yohannan","doi":"10.1016/j.ajo.2025.08.046","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Develop an artificial intelligence (AI) model to predict a personalized target intraocular pressure (IOP) for eyes with glaucoma. Compare the impact of achieving the AI-predicted, clinician-defined, and society guideline-based target IOP on rates of visual field (VF) worsening.</div></div><div><h3>Design</h3><div>Development and evaluation of an AI treatment algorithm</div></div><div><h3>Subjects</h3><div>A dataset of 14,871 eyes with a defined target IOP (set by glaucoma specialists during routine clinical care) and baseline OCT, VF, and clinical measurements. A non-overlapping progression dataset of 10,559 eyes with longitudinal VF testing (≥ 5 reliable tests).</div></div><div><h3>Methods</h3><div>We trained and tested a machine-learning model on the dataset of eyes with baseline structural, functional, and clinical data to predict a target IOP for each eye in the progression dataset. Linear models estimated the effect of mean target difference (measured IOP – target IOP) on the rate of VF worsening, defined by mean deviation (MD) slope. The effect of deviations from AI targets was compared to deviations from clinician-set targets and targets from society-based guidelines by the Canadian Ophthalmological Society (COS). Linear models also estimated the effect of mean absolute IOP on the rate of VF worsening. The effect of mean target difference (AI, clinician, or COS) was compared to the effect of mean absolute IOP.</div></div><div><h3>Main outcome measures</h3><div>Effect of 1 mm Hg increase in mean target difference (AI, clinician, or COS) on the rate of MD worsening (dB/year).</div></div><div><h3>Results</h3><div>The AI model achieved a mean absolute error of 2.28 mm Hg for predicting target IOP. AI and clinician target differences had similar effects on VF outcomes (0.032 dB/year vs 0.026 dB/year faster rate of MD worsening per 1 mm Hg increase, respectively, <em>p</em> = 0.09). AI and clinician target difference had greater effects than COS target difference (0.011 dB/year faster per 1 mm Hg increase, <em>p</em> < 0.001) and mean absolute IOP (0.001 dB/year faster per 1 mm Hg increase, <em>p</em> < 0.001).</div></div><div><h3>Conclusions</h3><div>AI models can set target IOP with comparable performance to glaucoma specialists and are superior to utilizing mean IOP or society-based guidelines to set targets. Further work is needed to assess the clinical impact of AI-based target IOP guidance for patients managed by non-glaucoma specialists.</div></div>","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":"280 ","pages":"Pages 423-435"},"PeriodicalIF":4.2000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002939425004623","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
Develop an artificial intelligence (AI) model to predict a personalized target intraocular pressure (IOP) for eyes with glaucoma. Compare the impact of achieving the AI-predicted, clinician-defined, and society guideline-based target IOP on rates of visual field (VF) worsening.
Design
Development and evaluation of an AI treatment algorithm
Subjects
A dataset of 14,871 eyes with a defined target IOP (set by glaucoma specialists during routine clinical care) and baseline OCT, VF, and clinical measurements. A non-overlapping progression dataset of 10,559 eyes with longitudinal VF testing (≥ 5 reliable tests).
Methods
We trained and tested a machine-learning model on the dataset of eyes with baseline structural, functional, and clinical data to predict a target IOP for each eye in the progression dataset. Linear models estimated the effect of mean target difference (measured IOP – target IOP) on the rate of VF worsening, defined by mean deviation (MD) slope. The effect of deviations from AI targets was compared to deviations from clinician-set targets and targets from society-based guidelines by the Canadian Ophthalmological Society (COS). Linear models also estimated the effect of mean absolute IOP on the rate of VF worsening. The effect of mean target difference (AI, clinician, or COS) was compared to the effect of mean absolute IOP.
Main outcome measures
Effect of 1 mm Hg increase in mean target difference (AI, clinician, or COS) on the rate of MD worsening (dB/year).
Results
The AI model achieved a mean absolute error of 2.28 mm Hg for predicting target IOP. AI and clinician target differences had similar effects on VF outcomes (0.032 dB/year vs 0.026 dB/year faster rate of MD worsening per 1 mm Hg increase, respectively, p = 0.09). AI and clinician target difference had greater effects than COS target difference (0.011 dB/year faster per 1 mm Hg increase, p < 0.001) and mean absolute IOP (0.001 dB/year faster per 1 mm Hg increase, p < 0.001).
Conclusions
AI models can set target IOP with comparable performance to glaucoma specialists and are superior to utilizing mean IOP or society-based guidelines to set targets. Further work is needed to assess the clinical impact of AI-based target IOP guidance for patients managed by non-glaucoma specialists.
期刊介绍:
The American Journal of Ophthalmology is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and visual science specialists describing clinical investigations, clinical observations, and clinically relevant laboratory investigations. Published monthly since 1884, the full text of the American Journal of Ophthalmology and supplementary material are also presented online at www.AJO.com and on ScienceDirect.
The American Journal of Ophthalmology publishes Full-Length Articles, Perspectives, Editorials, Correspondences, Books Reports and Announcements. Brief Reports and Case Reports are no longer published. We recommend submitting Brief Reports and Case Reports to our companion publication, the American Journal of Ophthalmology Case Reports.
Manuscripts are accepted with the understanding that they have not been and will not be published elsewhere substantially in any format, and that there are no ethical problems with the content or data collection. Authors may be requested to produce the data upon which the manuscript is based and to answer expeditiously any questions about the manuscript or its authors.